Find the right fit for you - faster
Get tailored insights about working at Inimmune in one quick step.
Inimmune Snapshot
Inimmune is harnessing the human immune system to create next generation immunotherapeutics for the treatment of allergy, infectious disease, autoimmunity and cancer. Our team has over 20 years of expertise in discovering and developing safe and effective immunomodulators that can be used for the treatment of a wide array of diseases and disorders. We have a proven track record of innovation, intellectual property generation, effective collaboration and sourcing of external funding to drive our immune therapies forward.
Inimmune was formed from an experienced, close-knit team of biotech/pharmaceutical industry professionals. This team of chemists, immunologists and formulation scientists have been at the cutting edge of innovation for over 10 years as former GSK Vaccines scientists and investigators. They now are working to create new immunotherapies directed at making meaningful and lasting clinical impacts in the areas of allergy, autoimmunity, infectious disease and cancer. Through its technology, assets, expertise and favorable IP positioning, Inimmune is poised to stand up and become a leader in the fields of immunotherapy, infectious disease and immuno-oncology. Inimmune is headquartered in beautiful Montana. It is located in Missoula, a culturally vibrant community of about 70,000, surrounded by mountain grandeur which was recently ranked in the “top 20 best college towns with a population of less than 250,000” by the American Institute for Economic Research and ranked 9th in Outside Magazine’s “The 16 Greatest Places to Live in America” in 2014. Many national publications recognize Missoula for its high quality of life. Abundant recreational opportunities in surrounding state and national forests and nearby Glacier National Park and Yellowstone National Park complement a thriving intellectual atmosphere.
